Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea
2026年6月17日 更新者：Nisa Nur Demirtaş、Ataturk University
Effect of Emotional Freedom Techniques on Pain Intensity, Pain Catastrophizing, and Functional-Emotional Impact in Nursing Students With Primary Dysmenorrhea
This study will examine whether Emotional Freedom Techniques (EFT) can reduce pain intensity, pain catastrophizing, and functional-emotional impact in nursing students with primary dysmenorrhea.
Eligible participants will be randomly assigned to an intervention group or a control group.
The intervention group will receive EFT-based support, and the control group will continue their usual coping practices.
Study outcomes will be measured before the intervention, after the intervention, and at follow-up.
This study may provide evidence for a safe, non-pharmacological approach to support students with primary dysmenorrhea.
調査の概要
研究の種類
介入
入学 (推定)
92
段階
- 適用できない
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
いいえ
説明
Inclusion Criteria:
- Being enrolled in a nursing program,
- Being 18 years of age or older
- Having had a regular menstrual cycle within the last six months
- Experiencing primary dysmenorrhea during the last three menstrual cycles
- Reporting moderate to severe pain according to the Visual Analog Scale (VAS: 4-10)
- Voluntary participation in the study
- Providing written informed consent
Exclusion Criteria:
- Having a diagnosed gynecological disease that may cause secondary dysmenorrhea (endometriosis, adenomyosis, uterine fibroids, pelvic inflammatory disease, etc.)
- Having chronic pain syndrome
- Receiving regular treatment or taking psychiatric medication due to a psychiatric diagnosis
- Applying another pharmacological or non-pharmacological intervention that may affect pain perception during the research process,
- Taking the course Obstetrics, Gynecology and Women's Health Nursing • Receiving/having received emotional freedom technique training,
- Having previously received training in this technique or regularly using it
- Having a cognitive or sensory problem that prevents communication or completing data collection forms
- Not completing the application protocol
- Incomplete completion of data collection forms
- Wishing to withdraw from the research
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Experimental Group
Participants in the experimental group will receive a structured Emotional Freedom Techniques (EFT)-based nursing intervention.
The intervention will include an individual preparation and education session 5-7 days before the expected menstruation, followed by a guided EFT session on the first day of menstrual pain.
Participants will also be encouraged to perform self-application 1-2 times on the same day.
|
The intervention consists of a structured Emotional Freedom Techniques (EFT)-based nursing intervention designed for nursing students with primary dysmenorrhea.
It includes an individual preparation and education session conducted 5-7 days before the expected menstruation, during which pain-related thoughts, emotions, and bodily awareness are identified and individualized setup statements are developed.
A guided EFT session is then conducted on the first day of menstrual pain.
During this session, participants focus on dysmenorrhea-related distress while repeating the individualized setup statements and following the structured EFT sequence under researcher guidance.
Pain intensity and subjective distress are assessed before and after the guided session.
Participants are also advised to repeat the EFT self-application 1-2 times on the same day.
|
|
介入なし：Control Grup
Participants in the control group will not receive the EFT-based nursing intervention during the study period and will continue their usual coping methods for menstrual pain without any additional structured support.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Pain Intensity
時間枠：Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Pain intensity will be assessed using the Visual Analog Scale (VAS).
Participants will rate the most severe menstrual pain experienced during the relevant menstrual cycle on a 0-10 scale, where 0 indicates no pain and 10 indicates the worst imaginable pain.
|
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
|
Pain Catastrophizing
時間枠：Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS).
Total scores range from 0 to 52.
Higher scores indicate greater pain catastrophizing and therefore a worse outcome.
|
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
|
Functional-Emotional Impact
時間枠：Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
Functional-emotional impact will be assessed using the Functional and Emotional Dysmenorrhea Scale (FEDS).
Total scores range from 14 to 70.
Higher scores indicate greater functional and emotional impact of dysmenorrhea and therefore a worse outcome.
|
Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (推定)
2026年6月19日
一次修了 (推定)
2026年10月19日
研究の完了 (推定)
2026年12月19日
試験登録日
最初に提出
2026年6月12日
QC基準を満たした最初の提出物
2026年6月17日
最初の投稿 (実際)
2026年6月22日
学習記録の更新
投稿された最後の更新 (実際)
2026年6月22日
QC基準を満たした最後の更新が送信されました
2026年6月17日
最終確認日
2026年6月1日
詳しくは
本研究に関する用語
その他の研究ID番号
- B.30.2.ATA.0.01.00/252
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
いいえ
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
いいえ
米国FDA規制機器製品の研究
いいえ
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。